Angela Zubel
InvestorChief Development Officer, Research & Development at Debiopharm Innovation Fund
Japan
About
Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
Experience
- Debiopharm International SAChief Development Officercurrent2019 — presentLausanne, Vaud, Switzerland
- SandozGlobal Head Clinical Development Biopharmaceuticals a.i.2017 — 2019Greater Munich Metropolitan Area
- SandozClinical Development Unit Head, Oncology2016 — 2017Greater Munich Metropolitan Area
- Novartis Institutes for BioMedical Research (NIBR)Clinical Program Leader, Oncology2011 — 2016Basel, Basel, Switzerland
- Healthcare Business of MerckMedical Leader, Oncology2004 — 2010Darmstadt, Hesse, Germany
Colleagues at Debiopharm Innovation Fund
Bertrand Ducrey
Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund
Cedric Odje
Investment Associate at Debiopharm Innovation Fund
Frédéric Lévy
Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund
Marc Cikes
Managing Director at Debiopharm Innovation Fund
Nicolas Favre
Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund
Nicolas Stalder
Senior Investment Associate at Debiopharm Innovation Fund
Pierre Jullian
Chief Finance Officer, Finance, HR, IT & Administration at Debiopharm Innovation Fund
Sara Picó
Investor at Debiopharm Innovation Fund
Frequently asked questions
- Who is Angela Zubel?
- Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
- Where does Angela Zubel work?
- Angela Zubel is Chief Development Officer, Research & Development at Debiopharm Innovation Fund.
- Where did Angela Zubel go to school?
- Angela Zubel studied at Heidelberg University (Doctor of Medicine - MD); Jagiellonian University.
Same school
Also attended Heidelberg University68
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi VenturesStella PaffenholzSenior Associate at Atlas Venture
+ 62 more
Also attended Jagiellonian University29
Ola JewusiakVP of Marketing at Jump CapitalMarguerite BensonSenior Advisor at Audere CapitalMagda PoslusznyPrincipal at Partech VenturesJoanna SorokaInvestment Partner at Hitachi VenturesAlexander KölpinFounder and Managing Director at Seed+SpeedKarolina ZapadkaSenior Investment Manager at Parkwalk Advisors
+ 23 more
Shared employers
Also worked at Sandoz12
Nikita SharmaPrincipal at Versant VenturesMax EisenbergChief Operating Officer and General Counsel at Versant VenturesCarol LynchAdvisor at Delin VenturesShreeram AradhyeInvestor at Novartis Venture FundMax PalkoPrincipal at Rockaway VenturesIain RossNon-Executive Director at Tern
+ 6 more
Also worked at Novartis Institutes for BioMedical Research (NIBR)173
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 167 more
Also worked at Healthcare Business of Merck15
Giovanni MariggiInvestor at MedicxiRoel BulthuisInvestor at SynconaMathias FalcenbergVenture Partner at V-Bio VenturesParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesDominic HarrisHead of Portfolio Management at Calculus Capital Ltd.Bar RubinAssociate at Rabo Corporate Venturing
+ 9 more